Heart transplantation in patients with hypertrophic cardiomyopathy

Authors

  • Marta Farrero Torres IDC salud, Hospital General de Catalunya, Barcelona, Spain and Universitat Internacional de Catalunya (UIC), Barcelona, Spain
  • Felix Perez-Villa Hospital Clinic de Barcelona, Spain

DOI:

https://doi.org/10.21542/gcsp.2018.32

Abstract

[first paragraph of article]

Hypertrophic cardiomyopathy has a broad spectrum of clinical presentations, from asymptomatic to patients with advanced heart failure and sudden death. Treatment options are limited, especially in non-obstructive forms. A minority of patients (around 3.5%) can progress to an end-stage state, characterized by systolic dysfunction and restrictive ventricular filling, related to extensive fibrotic replacement and chamber remodeling. In these cases, life expectancy is significantly reduced: a mean 3-year survival time has been reported.

Downloads

Published

2018-10-24

Issue

Vol. 2018 No. 3 (2018)

Section

Review articles

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.